Year Wise Statistics
Total Downloads
103,014
Fulltext
58,441
PDF
44,573
103,014
Fulltext
58,441
44,573
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text |  PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_3_2021 |
1,899 | 866 | 2,765 |
Review ArticleJAK inhibitors in dermatologyFull text | PDF Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_7_2021 |
1,486 | 934 | 2,420 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_44_2023 |
1,541 | 848 | 2,389 |
ObituaryObituary – Professor Marcus Maurer (1966–2024)Full text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_47_2024 |
1,812 | 552 | 2,364 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_5_2021 |
1,383 | 969 | 2,352 |
Review ArticleAssessing eczema severity: A comprehensive review of scoring systemsFull text | PDF Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_50_2024 |
1,929 | 295 | 2,224 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_50_2023 |
1,339 | 585 | 1,924 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_9_2024 |
1,047 | 842 | 1,889 |
Review ArticleA review of comorbidities in atopic dermatitisFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2024 |
1,078 | 665 | 1,743 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_16_2024 |
1,155 | 560 | 1,715 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_14_2023 |
892 | 719 | 1,611 |
Original ArticleIntestinal parasitic infestations in adult chronic spontaneous urticaria patients and the relation between them: A case–control studyFull text | PDF Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_52_2024 |
1,488 | 108 | 1,596 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_26_2023 |
907 | 672 | 1,579 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_45_2023 |
828 | 677 | 1,505 |
Letter to EditorTherapeutic unresponsiveness of gabapentin and hydroxyzine combination in moderate-severe chronic prurigo nodularis of HydeFull text | PDF DOI: 10.25259/IJSA_43_2024 |
1,100 | 374 | 1,474 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text | PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_11_2021 |
672 | 779 | 1,451 |
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_31_2023 |
680 | 712 | 1,392 |
Case ReportA rare presentation of pompholyx in a child mimicking bullous pemphigoidFull text | PDF Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_45_2024 |
1,021 | 316 | 1,337 |
EditorialDermatology practice in a high-tech worldFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_44_2024 |
822 | 480 | 1,302 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text | PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_4_2022 |
649 | 612 | 1,261 |
SymposiumChronic actinic dermatitisFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_10_2024 |
721 | 522 | 1,243 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_3_2024 |
537 | 661 | 1,198 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_6_2024 |
699 | 498 | 1,197 |
Case SeriesAngina bullosa hemorrhagica: A case series of a rare entityFull text | PDF Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_33_2024 |
923 | 256 | 1,179 |
Letter to EditorVitamin D levels in patients with chronic spontaneous urticariaFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_3_2023 |
423 | 752 | 1,175 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_20_2023 |
631 | 528 | 1,159 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_52_2023 |
579 | 570 | 1,149 |
Review ArticleAnaphylaxis – A must know for allFull text | PDF Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_9_2022 |
629 | 519 | 1,148 |
SymposiumPolymorphous light eruptionsFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_8_2024 |
630 | 496 | 1,126 |
Review ArticleUrticaria and comorbiditiesFull text | PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_5_2022 |
567 | 557 | 1,124 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text | PDF Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_22_2022 |
517 | 600 | 1,117 |
Original ArticleManagement of chronic spontaneous urticaria: Real-world Indian perspectiveFull text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_4_2021 |
508 | 605 | 1,113 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_12_2021 |
503 | 591 | 1,094 |
Letter to EditorAllergic contact dermatitis in children with atopic cheilitis and eyelid dermatitis – A case seriesFull text | PDF Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_49_2024 |
821 | 221 | 1,042 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_19_2024 |
447 | 591 | 1,038 |
Review ArticleA review of biological agents and small molecules in the management of atopic dermatitisFull text | PDF Year: 2023, Volume: 2, Issue: 2, July-December DOI: 10.25259/IJSA_18_2023 |
456 | 582 | 1,038 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_25_2023 |
305 | 730 | 1,035 |
SymposiumCutaneous photobiologyFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_11_2024 |
413 | 606 | 1,019 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_5_2024 |
500 | 517 | 1,017 |
CommentaryThe global atopic dermatitis atlas: Addressing international gaps in the disease burdenFull text | PDF Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_4_2025 |
884 | 116 | 1,000 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_48_2023 |
419 | 567 | 986 |
Case ReportA novel pitch against the itchFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_13_2024 |
375 | 604 | 979 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_15_2024 |
352 | 613 | 965 |
Review ArticleRole of patient-reported outcome measures in the management of chronic urticaria and angioedemaFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_6_2022 |
411 | 546 | 957 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2023 |
449 | 505 | 954 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDF Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_42_2023 |
379 | 574 | 953 |
Review ArticleGenital contact dermatitisFull text | PDF Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_56_2024 |
819 | 101 | 920 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_14_2024 |
391 | 515 | 906 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_51_2023 |
349 | 555 | 904 |
Conference ReportConference report: 8th Annual National Skin Allergy Meeting – IndiaFull text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_2_2022 |
418 | 483 | 901 |
